PRISMASOL BGK 4 Drug Patent Profile

Which patents cover Prismasol Bgk 4, and when can generic versions of Prismasol Bgk 4 launch?

Prismasol Bgk 4 is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.

The generic ingredient in PRISMASOL BGK 4 is calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride profile page.

Summary for PRISMASOL BGK 4

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	PRISMASOL BGK 4 at DailyMed

US Patents and Regulatory Information for PRISMASOL BGK 4

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	PRISMASOL BGK 4/0 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride	INJECTABLE;INJECTION	021703-005	Oct 25, 2006		DISCN	No	No
Baxter Hlthcare Corp	PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride	INJECTABLE;INJECTION	021703-008	Oct 25, 2006		DISCN	No	No
Baxter Hlthcare Corp	PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride	INJECTABLE;INJECTION	021703-015	Oct 10, 2008		RX	Yes	Yes
Baxter Hlthcare Corp	PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride	INJECTABLE;INJECTION	021703-004	Oct 25, 2006		RX	Yes	Yes